Literature DB >> 7898482

Transcriptional regulation and autoregulation of the human gene for ADP-ribosyltransferase.

S L Oei1, H Herzog, M Hirsch-Kauffmann, R Schneider, B Auer, M Schweiger.   

Abstract

Human nuclear poly(ADP-ribosyl)transferase (ADPRT) modifies proteins with branched ADP-ribose-polymers. Various proteins, including ADPRT itself, serve as acceptors for polyADP-ribose. Target proteins include those controlling basic cellular processes such as DNA repair, differentiation and proliferation. Because of the outstanding features of this enzyme: automodification, several functional domains and central role in physiology of the cell, the molecular biology of ADPRT gained wide interest. The promoter structure contains several CCAAT/TATA boxes and SP1 sites. However, there is no CCAAT/TATA box in the neighbourhood of an SP1 site and, thus no obvious site for initiation of transcription. Within this region there are several noteworthy inverted repeats, which by internal basepairing could form two types of cruciform structures. Deletion analysis revealed that these cruciform structures have functional significance. Removal of one type increases the promoter activity, whereas removal of the other diminishes the promoter function. Overexpression of ADPRT from heterologous promoters (MMTV, SV40) leads to repression of the activity of the ADPRT promoter. Indeed, ADPRT was shown to bind specifically to one type of cruciform structure. This specific interaction indicates autorepression of the ADPRT gene: the enzyme ADPRT acts directly as a negative modulator of the activity of its own promoter.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7898482     DOI: 10.1007/bf00928449

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  18 in total

1.  Primary structure of human poly(ADP-ribose) synthetase as deduced from cDNA sequence.

Authors:  T Kurosaki; H Ushiro; Y Mitsuuchi; S Suzuki; M Matsuda; Y Matsuda; N Katunuma; K Kangawa; H Matsuo; T Hirose
Journal:  J Biol Chem       Date:  1987-11-25       Impact factor: 5.157

2.  The interaction of adenosine diphosphoribosyl transferase (ADPRT) with a cruciform DNA.

Authors:  S S Sastry; E Kun
Journal:  Biochem Biophys Res Commun       Date:  1990-03-16       Impact factor: 3.575

3.  The second zinc-finger domain of poly(ADP-ribose) polymerase determines specificity for single-stranded breaks in DNA.

Authors:  G Gradwohl; J M Ménissier de Murcia; M Molinete; F Simonin; M Koken; J H Hoeijmakers; G de Murcia
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

Review 4.  ADP-ribosylation of proteins. Enzymology and biological significance.

Authors:  F R Althaus; C Richter
Journal:  Mol Biol Biochem Biophys       Date:  1987

5.  Differential expression and stability of poly(ADP-ribose)polymerase mRNA in human cells.

Authors:  M Negroni; U Bertazzoni
Journal:  Biochim Biophys Acta       Date:  1993-05-28

6.  Structure and function of the promoter of the carrot V-type H(+)-ATPase catalytic subunit gene.

Authors:  I Struve; T Rausch; P Bernasconi; L Taiz
Journal:  J Biol Chem       Date:  1990-05-15       Impact factor: 5.157

7.  Human nuclear NAD+ ADP-ribosyltransferase(polymerizing): organization of the gene.

Authors:  B Auer; U Nagl; H Herzog; R Schneider; M Schweiger
Journal:  DNA       Date:  1989-10

8.  Cell cycle-related expression of poly(ADP-ribosyl)transferase in proliferating rat thymocytes.

Authors:  K H Wein; R Netzker; K Brand
Journal:  Biochim Biophys Acta       Date:  1993-03-10

9.  The homeo domain of a murine protein binds 5' to its own homeo box.

Authors:  A Fainsod; L D Bogarad; T Ruusala; M Lubin; D M Crothers; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

10.  Isolation of a cDNA clone for human NAD+: protein ADP-ribosyltransferase.

Authors:  R Schneider; B Auer; C Kühne; H Herzog; H Klocker; H J Burtscher; M Hirsch-Kauffmann; U Wintersberger; M Schweiger
Journal:  Eur J Cell Biol       Date:  1987-10       Impact factor: 4.492

View more
  7 in total

1.  A caveat in mouse genetic engineering: ectopic gene targeting in ES cells by bidirectional extension of the homology arms of a gene replacement vector carrying human PARP-1.

Authors:  Aswin Mangerich; Harry Scherthan; Jörg Diefenbach; Ulrich Kloz; Franciscus van der Hoeven; Sascha Beneke; Alexander Bürkle
Journal:  Transgenic Res       Date:  2008-11-26       Impact factor: 2.788

2.  YY1-binding sites provide central switch functions in the PARP-1 gene expression network.

Authors:  Martina Doetsch; Angela Gluch; Goran Poznanović; Juergen Bode; Melita Vidaković
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

3.  Chromatin composition is changed by poly(ADP-ribosyl)ation during chromatin immunoprecipitation.

Authors:  Sascha Beneke; Kirstin Meyer; Anja Holtz; Katharina Hüttner; Alexander Bürkle
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

4.  Association analysis of PARP1 polymorphisms with Parkinson's disease.

Authors:  Laura Brighina; Chiara Riva; Francesca Bertola; Silvia Fermi; Enrico Saracchi; Roberto Piolti; Stefano Goldwurm; Gianni Pezzoli; Carlo Ferrarese
Journal:  Parkinsonism Relat Disord       Date:  2011-07-20       Impact factor: 4.891

5.  The Correlation Between PARP1 and BRCA1 in AR Positive Triple-negative Breast Cancer.

Authors:  Jiayan Luo; Juan Jin; Fang Yang; Zijia Sun; Wenwen Zhang; Yaqin Shi; Jing Xu; Xiaoxiang Guan
Journal:  Int J Biol Sci       Date:  2016-11-25       Impact factor: 6.580

6.  Regulation of chromatin structure by poly(ADP-ribosyl)ation.

Authors:  Sascha Beneke
Journal:  Front Genet       Date:  2012-09-03       Impact factor: 4.599

7.  PARP inhibition versus PARP-1 silencing: different outcomes in terms of single-strand break repair and radiation susceptibility.

Authors:  Camille Godon; Fabrice P Cordelières; Denis Biard; Nicole Giocanti; Frédérique Mégnin-Chanet; Janet Hall; Vincent Favaudon
Journal:  Nucleic Acids Res       Date:  2008-07-04       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.